Delivery Order SPE2DB25D3018-SPE2DB25FUWUK
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,059.39 firm fixed-price delivery order is for the supply of QUVIVIQ 25 MG TABLET 30S, a medication, to support military healthcare programs. The contract has an ultimate completion date of March 6, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,481.60 and is for the delivery of QUVIVIQ 50 MG TABLET 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,692.28 Delivery Order contract is for the supply of the medication QUVIVIQ 50 MG TABLET 30S, with a period of performance through November 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.36 firm fixed-price delivery order is for the supply of the prescription medication QUVIVIQ 50 MG TABLET 30S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,015.50, is a Delivery Order for the supply of QUVIVIQ 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 22, 2024, and is a Firm Fixed Price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,516.74 Firm Fixed Price Delivery Order is for the supply of the prescription medication QUVIVIQ 25 MG TABLET 30S, with a completion date of June 21, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,601.86, is for the delivery of QUVIVIQ 25 MG TABLET 30S, a prescription medication. The contract is a Firm Fixed Price (FFP) arrangement with a completion date of May 29, 2025. AmerisourceBergen Drug Corp is the prime contractor for this award, which is not set-aside. The...
- This federal contract award is for the delivery of the pharmaceutical product QUVIVIQ 50 MG TABLET 30S to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $1,112.65 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 10, 2024, with an ultimate completion date of September 11, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $2,712.98 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,850.10 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50mg tablets (30-count) under a firm fixed price contract type. The award was made on December 19, 2025, with an ultimate completion date of December 22, 2025. This is an unset-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUWUKDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,575.24 firm fixed-price delivery order is for the supply of QUVIVIQ 25 MG TABLET 30S, a medication, to support military healthcare programs. The contract has an ultimate completion date of February 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 2/7/25 |